FDA vs. EU Requirements for Decentralized Clinical Trials: A Practical Comparison
FDA and EU frameworks for decentralized clinical trials share core expectations around participant protection, investigator oversight, data integrity, and safety. However, implementation differs across jurisdictions. In the US, FDA provides specific guidance for decentralized trial elements, while in the EU, sponsors must consider the common clinical trial framework alongside applicable Member State provisions.